Lion Point Capital, LP - VASCULAR BIOGENICS LTD ownership

VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 28 filers reported holding VASCULAR BIOGENICS LTD in Q1 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lion Point Capital, LP ownership history of VASCULAR BIOGENICS LTD
ValueSharesWeighting
Q2 2022$5,751,000
+31.2%
2,593,2860.0%0.66%
-35.6%
Q1 2022$4,382,000
-14.2%
2,593,2860.0%1.02%
-25.7%
Q4 2021$5,108,0002,593,2861.37%
Other shareholders
VASCULAR BIOGENICS LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 152,764$365,0000.50%
Ikarian Capital, LLC 800,811$1,915,0000.16%
DAFNA Capital Management LLC 306,980$734,0000.15%
PVG ASSET MANAGEMENT CORP 12,155$29,050,0000.09%
Phoenix Holdings Ltd. 1,060,300$2,534,0000.05%
Virtu Financial LLC 39,618$95,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 89,689$214,0000.01%
HBK Sorce Advisory LLC 22,000$53,0000.00%
MORGAN STANLEY 693,420$1,658,0000.00%
Bank of New York Mellon Corp 25,000$60,0000.00%
View complete list of VASCULAR BIOGENICS LTD shareholders